An accelerated mouse model for atherosclerosis and adipose tissue inflammation

por Neuhofer, Angelika, Wernly, Bernhard, Leitner, Lukas, Sarabi, Alisina, Sommer, Nicole G, Staffler, Günther, Zeyda, Maximilian, Stulnig, Thomas M
Publicado 2014

Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity

por Tardelli, Matteo, Zeyda, Karina, Moreno-Viedma, Veronica, Wanko, Bettina, Grün, Nicole G., Staffler, Günther, Zeyda, Maximilian, Stulnig, Thomas M.
Publicado 2016

Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage

por Jürets, Alexander, Le Bras, Marie, Staffler, Günther, Stein, Gesine, Leitner, Lukas, Neuhofer, Angelika, Tardelli, Matteo, Turkof, Edvin, Zeyda, Maximilian, Stulnig, Thomas M.
Publicado 2016

Antibody-mediated targeting of cleavage-specific OPN-T cell interactions

por Wanko, Bettina, Tardelli, Matteo, Jürets, Alexander, Neuhofer, Angelika, Prager, Gerhard, Morser, John, Leung, Lawrence L., Staffler, Günther, Zeyda, Maximilian, Stulnig, Thomas M.
Publicado 2019

A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy

por Meissner, Wassilios G., Traon, Anne Pavy‐Le, Foubert‐Samier, Alexandra, Galabova, Gergana, Galitzky, Monique, Kutzelnigg, Alexandra, Laurens, Brice, Lührs, Petra, Medori, Rossella, Péran, Patrice, Sabatini, Umberto, Vergnet, Sylvain, Volc, Dieter, Poewe, Werner, Schneeberger, Achim, Staffler, Günther, Rascol, Olivier
Publicado 2020

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

por Zeitlinger, Markus, Bauer, Martin, Reindl-Schwaighofer, Roman, Stoekenbroek, Robert M., Lambert, Gilles, Berger-Sieczkowski, Evelyn, Lagler, Heimo, Oesterreicher, Zoe, Wulkersdorfer, Beatrix, Lührs, Petra, Galabova, Gergana, Schwenke, Carsten, Mader, Robert M., Medori, Rossella, Landlinger, Christine, Kutzelnigg, Alexandra, Staffler, Günther
Publicado 2021

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study

por Poewe, Werner, Volc, Dieter, Seppi, Klaus, Medori, Rossella, Lührs, Petra, Kutzelnigg, Alexandra, Djamshidian, Atbin, Thun-Hohenstein, Caroline, Meissner, Wassilios G., Rascol, Olivier, Schneeberger, Achim, Staffler, Günther, Poewe, Werner, Seppi, Klaus, Djamshidian, Atbin, deMarzi, Roberto, Heim, Beatrice, Mangesius, Stephanie, Stolz, Raphaela, Wachowicz, Katarzyna, Volc, Dieter, Thun-Hohenstein, Caroline, Riha, Constanze, Schneeberger, Achim, Bürger, Vera, Galabova, Gergana
Publicado 2021